Conavi Medical Corp. (TSXV:CNVI)

Canada · Delayed Price · Currency is CAD

0.3750

+0.0150 (4.17%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Development and Commercialization of Imaging Technologies	9.12M	2.16M	2.36M	2.70M
Development and Commercialization of Imaging Technologies Growth	322.12%	-8.59%	-12.44%	-
Total	9.12M	2.16M	2.36M	2.70M
Total Growth	322.12%	-8.59%	-12.44%	-

Revenue by Geography

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
North America (Excluding Canada)	5.00K	84.00K	46.00K	83.00K
North America (Excluding Canada) Growth	-94.05%	82.61%	-44.58%	-
Asia	9.12M	2.07M	2.29M	2.58M
Asia Growth	339.80%	-9.52%	-11.24%	-
Canada	-	4.00K	27.00K	36.00K
Canada Growth	-	-85.19%	-25.00%	-
Total	9.12M	2.16M	2.36M	2.70M
Total Growth	322.12%	-8.59%	-12.44%	-

Source: S&P Global Market Intelligence.